OTCMKTS:ASNB - AdvanSource Biomaterials Corpration Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.1298 -0.01 (-3.78 %)
(As of 04/24/2019 03:50 AM ET)
Previous Close$0.1349
Today's Range$0.1203 - $0.1298
52-Week Range$0.0281 - $0.1477
Volume3,832 shs
Average Volume48,751 shs
Market Capitalization$2.80 million
P/E Ratio12.80
Dividend YieldN/A
AdvanSource Biomaterials Corp. engages in the development of polymer materials which provide critical characteristics in the design and development of medical devices. Its biomaterials are used in devices that are designed for treating a range of anatomical sites and disease states. Its products include ChronoFlex, ChronoSil, HydroMed, HydroThane, and PolyBlend. The company was founded in 1993 and is headquartered in Wilmington, MA.

Receive ASNB News and Ratings via Email

Sign-up to receive the latest news and ratings for ASNB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Current SymbolOTCMKTS:ASNB



Sales & Book Value

Annual Sales$2.92 million
Book Value($0.02) per share


Net Income$-200,000.00


Market Cap$2.80 million
Next Earnings Date7/15/2019 (Estimated)
OptionableNot Optionable

AdvanSource Biomaterials Corpration (OTCMKTS:ASNB) Frequently Asked Questions

What is AdvanSource Biomaterials Corpration's stock symbol?

AdvanSource Biomaterials Corpration trades on the OTCMKTS under the ticker symbol "ASNB."

How were AdvanSource Biomaterials Corpration's earnings last quarter?

AdvanSource Biomaterials Corpration (OTCMKTS:ASNB) released its earnings results on Thursday, October, 16th. The company reported $0.31 EPS for the quarter, beating the Thomson Reuters' consensus estimate of $0.29 by $0.02. AdvanSource Biomaterials Corpration had a net margin of 10.09% and a negative return on equity of 62.83%. During the same quarter in the previous year, the company posted $0.27 earnings per share. View AdvanSource Biomaterials Corpration's Earnings History.

When is AdvanSource Biomaterials Corpration's next earnings date?

AdvanSource Biomaterials Corpration is scheduled to release their next quarterly earnings announcement on Monday, July 15th 2019. View Earnings Estimates for AdvanSource Biomaterials Corpration.

Has AdvanSource Biomaterials Corpration been receiving favorable news coverage?

News headlines about ASNB stock have been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. AdvanSource Biomaterials Corpration earned a news sentiment score of 1.6 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 1.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the stock's share price in the near future.

Who are some of AdvanSource Biomaterials Corpration's key competitors?

What other stocks do shareholders of AdvanSource Biomaterials Corpration own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AdvanSource Biomaterials Corpration investors own include Associated Banc (ASB), PermRock Royalty Trust (PRT), Interpace Diagnostics Group (IDXG), Sphere 3D (ANY), Champions Oncology (CSBR), GALAPAGOS NV/S (GLPG), Alphabet (GOOG), Insys Therapeutics (INSY), Netflix (NFLX) and OHR Pharmaceutical (OHRP).

Who are AdvanSource Biomaterials Corpration's key executives?

AdvanSource Biomaterials Corpration's management team includes the folowing people:
  • Michael F. Adams, President & Chief Executive Officer
  • Khristine L. Carroll, Senior Vice President-Commercial Operations

How do I buy shares of AdvanSource Biomaterials Corpration?

Shares of ASNB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is AdvanSource Biomaterials Corpration's stock price today?

One share of ASNB stock can currently be purchased for approximately $0.1298.

How big of a company is AdvanSource Biomaterials Corpration?

AdvanSource Biomaterials Corpration has a market capitalization of $2.80 million and generates $2.92 million in revenue each year. AdvanSource Biomaterials Corpration employs 11 workers across the globe.

What is AdvanSource Biomaterials Corpration's official website?

The official website for AdvanSource Biomaterials Corpration is http://www.advbiomaterials.com.

How can I contact AdvanSource Biomaterials Corpration?

AdvanSource Biomaterials Corpration's mailing address is 229 ANDOVER STREET, WILMINGTON MA, 01887. The company can be reached via phone at 978-657-0075 or via email at [email protected]

MarketBeat Community Rating for AdvanSource Biomaterials Corpration (OTCMKTS ASNB)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  48 (Vote Outperform)
Underperform Votes:  41 (Vote Underperform)
Total Votes:  89
MarketBeat's community ratings are surveys of what our community members think about AdvanSource Biomaterials Corpration and other stocks. Vote "Outperform" if you believe ASNB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ASNB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/24/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel